Relief Therapeutics Holding AG (RLFTF)

[Joe Kaplan]

Interesting Post that nots Cryptic on you know who>>>>>>>
Mav 3 hours ago
I got a reply from Relief about the Data They got the Trial report but did not get the underlying data and interestingly also about the patent. The inhaler patent for Aviptadil ( not a formulation)belongs to Relief through the acqisition of . So anyone going to inhaler need to licence it. Now you can see why Dr J is fighting

1) Relief said in a previous PR that they got the data from phase 2/3 of RLF100 from Neurorx but todays PR has a disclaimer that the data was not released to Relief. What is the truth?

Relief has not received the underlying data to the clinical study report which NRx provided to Relief, as mentioned in the June 2, 2021 press release. Relief is continuing to work with NRx to obtain the underlying data to the phase 2b/3 study of IV RLF-100.

2) How about the patent that Relief acquired through Advita? Is this patent based on a stable formulation or does it have similar stability issue like RLF100 that Neurorx mentioned?

With the acquisition, Relief has gained additional pending intellectual property rights that may cover RLF-100 inhaled formulation specifications and the potential application of inhaled aviptadil for the treatment of lung diseases such as acute respiratory distress syndrome (ARDS), pulmonary sarcoidosis and checkpoint inhibitor-induced pneumonitis (CIP).